Arysta LifeScience tightens OID on $175 million add-on loan to 99 7/8

By Sara Rosenberg

New York, Feb. 28 - Arysta LifeScience Corp. revised the original issue discount on its $175 million add-on first-lien term loan (B1/B) to 99 7/8 from talk of 99½ to 993/4, according to a market source.

Pricing on the loan is Libor plus 350 basis points with a 1% Libor floor, and there is 101 soft call protection through May 2014.

J.P. Morgan Securities LLC is the lead bank on the deal.

Proceeds will be used for general corporate purposes and to support acquisitions.

Arysta LifeScience is a Tokyo-based crop protection and life science company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.